Factor II, VII, IX, X, Protein C

Indications: for the therapy and prophylaxis of blood coagulating disorder caused by an acquired or hereditary deficiency of vitamin dependent factors II, VII, I and X

Contra-indications: Disseminated itrvascular coagulating or hyperfirinolsis, hypersensitivity

Side Effects: Circulating inhibitors, dyspnea, Nausea, vomiting, fever, hypersensitivity reactions, urticarial, hypotension, shock thromboembolic events

Pregnancy and Breast feeding: May be administered to only if clearly indicated and the benefit weights the risk.

Dose: The dosage and duration of the substitution therapy depend on the severity of disorder of the haemostatic function, on the location and extent of the bleeding and on the clinical condition Maintenance.